The expression of the SCIP and myelin genes (PLP, BP and MAG) was quantitated by Northern blot analysis during early postnatal rat brain development. The SCIP gene was already profoundly upregulated on day 1 postpartum. The SCIP message level in the forebrain was 4- and 17-fold higher than the message level in the cerebellum and brainstem, respectively. By day 20, the SCIP gene expression declined in the forebrain to approximately 5% of the day-1 level, and became undetectable in the brainstem and cerebellum. The myelin gene expression sharply upregulated at approximately day 7–8, and in general, was highest in the brainstem, and lowest in the forebrain. The results demonstrate that the expression of the SCIP gene in the oligodendrocytic lineage cells is relatively low, whereas other cellular elements feature very active expression of the gene during the early postnatal development. Additionally, the variation in the relative ratios of the myelin messages among the brain regions indicates that the levels of expression of the myelin genes are not tightly synchronized.

Keywords:
Brain development, Myelin genes, POU genes, SCIP gene
This content is only available via PDF.
© 1993 S. Karger AG, Basel
1994
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.